Athanasios Alexopoulos MEDICAL ONCOLOGY

• Doctoral Thesis: “Cancer Cachexia” University of Athens.

• Board member in Hellenic society of cancer research 
• Board member of Hellenic society of clinical oncologists 
• Hellenic Breast Cancer society 
• ESMO
• EORTC Breast Cooperative Group
• Board member of Hellenic society of Psychosocial Oncology
• Editorial board of medical edition “Hellenic Oncology”

Editorial Boards:

• Editorial board of medical edition “Hellenic Oncology”

• Liver Unit Kings College Hospital London 
• Guys Hospital Clinical London Oncology and Breast Unit
• Residencies and fellowships: 
• Medical Oncologist in Saint Savvas Hospital for 27 years 
• Medical Oncologist in Hygeia Hospital since 2007

Clinical Interest:

• Clinical interest in solid tumors with more interest in Breast Cancer

Research Interest:

• Research interest in all areas of cancer care related to Breast Cancer, endometrial cancer, ovarian cancer, NCSLC, bladder cancer, liver, cholangiocarcinoma and pancreatic cancer.
• My research is focused on prevention of Breast Cancer, prevention of recurrence after surgery, adjuvant treatment and treatment of recurrences. 

• Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast can-cer in Greece: An evaluation study Annals of Oncology 25 2014 and BMC Health Serv Res. 2015 Aug
• A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines J Cancer Res Cin Oncol. 2010 Jan
• Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER-2 positive recurrent breast cancer: find-ings from a case series Oncologie. 2005 Nov 
• In vivo synergism between docetaxel and gemcitabine in patients with meta-static breast cancer: general concepts and future perspectives Semin Oncol. 2004 Apr 
• Phase II sudy of pegylated liposomal doxorubicin (Caelyx) and docetaxel as first-line treatment in metastatic breast cancer Ann Oncol. 2004 Jun
• Evidence for in vivo synergism between docetaxel and gemcitabine in pa-tients with metastatic breast cancer Ann Oncol. 2004 Jan
• Gemcitabine plus irinotecan in breast cancer patients pretreated with tax-anes and anthracyclines: a multicenter phase II study Oncology. 2003
• Salvage treatment of metastatic breast cancer with docetaxel and car-boplatin. A multicenter phase II trial Oncology. 2003
• Docetaxel in combination with mitixantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study Ann Oncol. 2001 Jun
• Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomized multicenter trial Lancet. 2001 May